Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Photogen and Coherent Join on Eye Laser
Mar 1999
KNOXVILLE, Tenn., March 25 -- Photogen Technologies, Inc. and Coherent, Inc.'s Laser Group have jointly designed and built what is believed to be the first medical ultrafast laser device for treating ocular melanoma (a cancer of the eye) and advanced macular degeneration.
The new laser device utilizes Photogen's proprietary multi-photon activation technology and special beam focusing and scanning capabilities. Pre-clinical trials using this ultrafast laser device with various photoactive agents on patients with ocular melanoma and advanced macular degeneration are underway at Massachusetts Eye and Ear Infirmary, a Harvard Medical School teaching affiliate with which Photogen has a research agreement. The trials are expected to be completed in the near future.

News & Featuresultrafast laserslasers

Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.